- Home
- PLBC vs AQST Comparison
PLBC vs AQST Comparison
Compare PLBC & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBC
- AQST
- Stock Information
- Founded
- PLBC 1980
- AQST 2004
- Country
- PLBC United States
- AQST United States
- Employees
- PLBC N/A
- AQST N/A
- Industry
- PLBC Finance Companies
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- PLBC Finance
- AQST Health Care
- Exchange
- PLBC Nasdaq
- AQST Nasdaq
- Market Cap
- PLBC 253.9M
- AQST 285.4M
- IPO Year
- PLBC 2005
- AQST 2018
- Fundamental
- Price
- PLBC $44.73
- AQST $3.05
- Analyst Decision
- PLBC Buy
- AQST Strong Buy
- Analyst Count
- PLBC 2
- AQST 8
- Target Price
- PLBC $52.50
- AQST $10.38
- AVG Volume (30 Days)
- PLBC 11.2K
- AQST 1.6M
- Earning Date
- PLBC 01-21-2025
- AQST 03-04-2025
- Dividend Yield
- PLBC 2.43%
- AQST N/A
- EPS Growth
- PLBC N/A
- AQST N/A
- EPS
- PLBC 4.77
- AQST N/A
- Revenue
- PLBC $79,873,000.00
- AQST $58,900,000.00
- Revenue This Year
- PLBC N/A
- AQST $18.44
- Revenue Next Year
- PLBC $15.50
- AQST N/A
- P/E Ratio
- PLBC $9.38
- AQST N/A
- Revenue Growth
- PLBC 3.64
- AQST 22.56
- 52 Week Low
- PLBC $32.50
- AQST $2.24
- 52 Week High
- PLBC $51.33
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- PLBC 43.42
- AQST 29.54
- Support Level
- PLBC $41.90
- AQST $2.96
- Resistance Level
- PLBC $44.40
- AQST $3.79
- Average True Range (ATR)
- PLBC 1.49
- AQST 0.21
- MACD
- PLBC -0.42
- AQST -0.01
- Stochastic Oscillator
- PLBC 40.26
- AQST 10.84
About PLBC Plumas Bancorp
Plumas Bancorp is a bank holding company that provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.